Clinical Trials Logo
  1. Home
  2. Gene Expression
  3. NCT05327400

Expression and Clinical Significance of IGHD in Pancreatic Cancer

Gene Expression Clinical Trial

Official title:
Expression and Clinical Significance of IGHD in Pancreatic Cancer

Clinical Trial Summary

Background ： Pancreatic cancer is the most malignant tumor in the digestive system, with low level of early diagnosis and poor prognosis. There is a lack of high sensitive and specific molecular markers in the diagnosis, treatment and prognosis of pancreatic cancer. Objective： To explore the expression of IGHD in pancreatic cancer and its correlation with clinical parameters, and to explore its prognostic value in patients with pancreatic cancer. Methods： In this study, qRT-PCR was used to detect IGHD expression in peripheral blood. The expression of IGHD in pancreatic cancer and healthy individuals was compared. The PCR results were combined with clinical data of patients. To compare the expression of IGHD in different pancreatic cancer stages and evaluate whether IGHD expression in peripheral blood can be a potential biomarker for the diagnosis of pancreatic cancer, chi-square test was used to analyze the factors influencing the expression level of IGHD. Kaplan-Meier was used to analyze patient prognosis, and further Cox regression analysis was used to analyze the factors influencing patient prognosis and independent risk factors.

Clinical Trial Description

Methods：The expressions of IGHD in peripheral blood of about 30 patients with pancreatic cancer and more than 30 healthy controls were detected by qRT-PCR, and the differences of IGHD were analyzed.The expression of IGHD in pancreatic cancer and healthy individuals was compared. The PCR results were combined with clinical data of patients. To compare the expression of IGHD in different pancreatic cancer stages and evaluate whether IGHD expression in peripheral blood can be a potential biomarker for the diagnosis of pancreatic cancer, chi-square test was used to analyze the factors influencing the expression level of IGHD. Kaplan-Meier was used to analyze patient prognosis, and further Cox regression analysis was used to analyze the factors influencing patient prognosis and independent risk factors. Pancreatic cancer is a disease of digestive system with a high degree of malignancy. The level of early diagnosis and therapeutic effect are limited by the research status of pancreatic adenocarcinoma. Conventional CT, MRI and other methods have a limited level of early diagnosis of pancreatic cancer, and EUS and endoscope-guided needle biopsy are in the stage of clinical trials. Studies on novel markers involve protein, miRNA, exosome, methylation, protein and genomics, but there is no mature and practical diagnostic method. Based on the current diagnosis, treatment and prognosis level of pancreatic cancer, I made a bold attempt to study the expression of IGHD in pancreatic cancer and their relationship with clinical parameters and prognosis level, so as to screen molecular markers conducive to diagnosis, treatment and prognosis of pancreatic cancer and provide data support for improving the diagnosis and treatment level of pancreatic cancer. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05327400
Study type Observational [Patient Registry]
Source Affiliated Hospital of Nantong University
Contact Lu Y Yuhua, phd
Phone +86 13862815432
Email lyh76@126.com
Status Recruiting
Phase
Start date May 1, 2022
Completion date October 31, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT05620043 - Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler N/A
Recruiting NCT00918359 - Heat Intolerance- A Lesson From Global Genomic Response in Lymphocytes N/A
Completed NCT04868227 - Scottish Vitamin D Intervention Study N/A
Completed NCT01681394 - Effect of a Polyphenol-rich Cocoa Extract on Peripheral Blood Mononuclear Cells Gene Expression N/A
Completed NCT01723410 - Neural and Physiological Responses to Real-World Experiences N/A
Completed NCT04415697 - Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas
Recruiting NCT01321112 - Search for Transcriptional Biomarkers in a Conversion Protocol From Calcineurin Inhibitors to Mycophenolate Mofetil N/A
Completed NCT01316731 - MyoGene: Effects of Acute Exercise on (Myokine) Gene Expression in Human Skeletal Muscle N/A
Completed NCT00859196 - Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries Phase 4
Completed NCT01806441 - Impact of a Short-Term High Fat or Low Fat Diet on Intestinal Genes Expression Involved in the Cholesterol and Fatty Acid Metabolism N/A
Recruiting NCT04789057 - Atorvastatin Effect on Reduction of COPD Exacerbations Phase 4
Terminated NCT04737044 - Effects of Antioxidant Sugar vs Granulated Sugar on Metabolic Outcomes in Healthy and Cardio Metabolic Subjects N/A
Active, not recruiting NCT00972972 - Effect of Bilberry (European Blueberries) and Grape Polyphenols on Cognition and Blood Parameters Phase 0
Withdrawn NCT01524523 - Bone Marrow Aspiration Pain Study N/A
Completed NCT01052649 - Gene Expression Monitoring of Mononuclear Cells (MNC) Subpopulations and Immunological Status and Metabolome Defining of Healthy Population N/A